Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
SUNPHARMA Stock Analysis
Views
Red Flags
Positive
Strong price momentum
High and stable ROE
High and stable operating margin
Low Debt to Equity, not much change from last year
Company's earnings are of high quality
Consistently pays dividend
Company is net cash
Negative
Expensive and at a premium to industry median P/E
Analysts have been downgrading forward EPS estimates
Low revenue growth and in line with median growth of industry
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Not enough talking point with neutral stance
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
SUNPHARMA Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
SUNPHARMA Bulk, Block & Insider Trades
SUNPHARMA Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Stock split
Others
Bonus(1 new shares for 1 existing shares) Ex-date: 29th Jul 2013 Announced on: 28th May 2013
Bonus(1 new shares for 1 existing shares) Ex-date: 27th May 2004 Announced on: 22nd Apr 2004
Bonus(2 new shares for 1 existing shares) Ex-date: 6th Mar 2000 Announced on: 6th Mar 2000
Stock split(1 : 5)BOD 24 September 2010. Nominal value changes from INR 5 to INR 1. Ex-date: 25th Nov 2010 Announced on: 24th Sep 2010
Stock split(1 : 2) Ex-date: 13th Jan 2003 Announced on: 20th Dec 2002
Demerger (DEM)Demerger of Sun Pharma Advanced Research Company Limited (SPARC) from Sun Pharmaceutical Industries Limited (SPIL) in the nature of demerger and transfer of innovative Research and Development. SPIL Shareholders will be allotted 1 (One) no. of Equity share of Re. 1/- (One) each of SPARC for every 1 ... Read More Ex-date: 23rd Apr 2007 Announced on: 30th Mar 2007
MergerMERGER: The company has alloted 4274 Equity Shares of Rs 5/- each to shareholders of erstwhile Phlox Pharmaceuticals Ltd (Phlox) which got merged with the company. As per the scheme of amalgamation of the company One (1) Equity shares of the Company have been alloted for every Seven Hundred Ninety ... Read More Ex-date: 18th Aug 2005 Announced on: 22nd Aug 2005
MergerEquity shares to be alloted as per the scheme of amalgamation of M.J. Pharmaceuticals Inds. Ltd. with the company. There will be no dealing under the securities of M.J. Pharmaceuticals Ltd. Ex-date: 28th Aug 2002 Announced on: 1st Jul 2002
MergerAs per the scheme of amalgamation of Pradeep Drug Co. Ltd. with Sun Pharmaceutical Inds. Ltd. one equity share of 10 each of Sun Pharmaceutical Inds. alloted for five hundred equity shares of Rs.10 each of Pradeep Drug Co. Ltd. held. There is no dealings date under Pradeep Drugs Co. equity shares w... Read More Ex-date: 28th Feb 2002 Announced on: 21st Feb 2002
MergerAs per the scheme of amalgamation of Gujarat Lyka Organics with Sun Pharmaceuticals Inds. Ltd. 1 equity shares of Sun Pharmaceuticals will be alloted for every 21.33 existing equity shares of Gujarat Lyka Organics Ltd. There will be no dealing with effect from 2 May 2000 under Gujarat Lyka Organics Ltd. Ex-date: 16th Jan 2001 Announced on: 16th Jan 2001
Company Profile
Sun Pharmaceutical Industries Limited is an India-based specialty generic pharmaceutical company with a presence in specialty, generics and consumer healthcare products. The Companys global specialty portfolio spans products in dermatology, ophthalmology, and onco-dermatologym, among others. The Com... Read More
Key personnel
Mr. Dilip Shantilal ShanghviD
Executive Chairman of the Board
Ms. Jayashree Satagopan
Chief Financial Officer
Mr. Aalok Dilip ShanghviD
Whole-time Director and Chief Operating Officer
Mr. Anoop Deshpande
Compliance Officer, Company Secretary
Mr. Kirti Ganorkar
Managing Director
Ms. Vidhi Dilip ShanghviD
Whole-Time Director
Dr. Pawan Kumar GoenkaD
Lead Non-Executive Independent Director
Ms. Rama BijapurkarD
Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Sun Pharmaceutical Industries Ltd.?
The current share price of Sun Pharmaceutical Industries Ltd. is ₹ 1,729.93 as of 09 Jan 2026.
What is the PE ratio of Sun Pharmaceutical Industries Ltd.?
The Price-to-Earnings (PE) ratio of Sun Pharmaceutical Industries Ltd. is 39.72 as of the latest financial data.
What is the ROE and ROCE of Sun Pharmaceutical Industries Ltd.?
Sun Pharmaceutical Industries Ltd. has a Return on Equity (ROE) of 16.09% and a Return on Capital Employed (ROCE) of 17.33% as per the latest financial reports.
What is the market cap of Sun Pharmaceutical Industries Ltd.?
The market capitalization of Sun Pharmaceutical Industries Ltd. stands at ₹ 4,15,068.00 Cr.
What is the dividend yield of Sun Pharmaceutical Industries Ltd.?
The dividend yield of Sun Pharmaceutical Industries Ltd. is 0.92% based on the current market price.
What is the RSI of Sun Pharmaceutical Industries Ltd.?
The Relative Strength Index (RSI) of Sun Pharmaceutical Industries Ltd. is 44.31.
What is the FII and DII holding in Sun Pharmaceutical Industries Ltd.?
Foreign Institutional Investors (FII) hold 16.55% and Domestic Institutional Investors (DII) hold 18.45% of Sun Pharmaceutical Industries Ltd. shares.
What sector does Sun Pharmaceutical Industries Ltd. belong to?
Sun Pharmaceutical Industries Ltd. operates in the Healthcare sector.
What is the beta of Sun Pharmaceutical Industries Ltd. stock?
The beta of Sun Pharmaceutical Industries Ltd. stock is 0.71, indicating its volatility relative to the broader market.
